We recommend that you stay close to nature while using the sophistication of science inspired by Mother Nature, then created by the experts at Pure Caps® into one of the most respected and effective pharmaceutical grade supplements and nutraceuticals on the planet!
Pure Caps is committed to be the leader in the new frontier of preventive health nutrigenomics*. Brochure: Nutrigenomics
Watch William Li, M.D.: Can we eat to starve cancer? Answer: "YES!"
Dr. Li presents a new way to think about treating cancer and other diseases: anti-angiogenesis, preventing the growth of blood vessels that feed a tumor. The crucial first (and best) step: Eating cancer-fighting foods and nutraceuticals that cut off the supply lines and beat cancer at its own game.
Why you should listen to him. Many of society’s most devastating diseases -- cancer, cardiovascular disease, diabetes and Alzheimer’s, to name a few -- share a common denominator: faulty angiogenesis, the body’s growth of new capillary blood vessels. Given excessive or insufficient blood vessel growth, serious health issues arise. While researching under Harvard surgeon Judah Folkman, who pioneered the study of angiogenesis, Li learned how angiogenesis-based medicine helps patients overcome numerous diseases by restoring the balance of blood-vessel growth. Visit http://www.scienceofcancers.com/
Li co-founded the Angiogenesis Foundation http://www.angio.org/ in 1994. The foundation’s Project ENABLE -- a global system that integrates patients, medical experts and healthcare professionals -- democratizes the spread and implementation of knowledge about angiogenesis-based medicines, diet and lifestyle. Some 40,000 physicians have been educated on new treatments, ranging from cancer care to wound care, by the foundation’s faculty of medical experts, and they are bringing new, lifesaving and disease-preventing techniques to people around the world.
Watch: Jay Bradner, MD: Open-source cancer research
A doctor and a chemist, Jay Bradner hunts for new approaches to solving cancer. As a research scientist and instructor in medicine at Harvard and Dana Farber Cancer Institute, he and his lab are working to subvert cancer's aggressive behavior by reprogramming the cell's fundamental identity. A molecule they're working on, JQ1, might do just that. (And he’s giving it away in order to spur faster open-source drug discovery.) If you're a researcher who'd like a sample of the JQ1 molecule, contact the Bradner Lab. email@example.com
Watch David Agus, MD: A new strategy in the war on cancer.
Traditionally, Dr. David Agus, MD, explains, cancer treatments have had a short-sighted focus on the offending individual cells. He suggests a new, cross-disciplinary approach, using atypical drugs, computer modeling and protein analysis to treat and analyze the whole body.